Pia Wegman

Summary

Country: Sweden

Publications

  1. doi request reprint Expression of the forkhead transcription factor FOXL2 correlates with good prognosis in breast cancer patients treated with tamoxifen
    Pia Wegman
    Department of Clinical Medicine, School of Health and Medical Sciences, Orebro University, 701 85 Orebro, Sweden
    Int J Oncol 38:1145-51. 2011
  2. doi request reprint Genetic alterations in the K-Ras gene influence the prognosis in patients with cervical cancer treated by radiotherapy
    Pia Wegman
    Division of Clinical Medicine, School of Health and Medical Sciences, Orebro University, Orebro, Sweden
    Int J Gynecol Cancer 21:86-91. 2011
  3. doi request reprint Wwox expression may predict benefit from adjuvant tamoxifen in randomized breast cancer patients
    Anna Göthlin Eremo
    School of Health and Medical Sciences, Orebro University, SE 70182 Orebro, Sweden
    Oncol Rep 29:1467-74. 2013
  4. pmc The mitochondrial transporter SLC25A43 is frequently deleted and may influence cell proliferation in HER2-positive breast tumors
    Elisabet Tina
    Clinical Research Centre, Orebro University Hospital, SE 70185, Orebro, Sweden
    BMC Cancer 12:350. 2012
  5. doi request reprint Conformational enantiomerization and estrogen receptor α binding of anti-cancer drug tamoxifen and its derivatives
    Li Gao
    Orebro Life Science Center, School of Science and Technology, Orebro University, Orebro, Sweden
    J Chem Inf Model 51:306-14. 2011

Detail Information

Publications5

  1. doi request reprint Expression of the forkhead transcription factor FOXL2 correlates with good prognosis in breast cancer patients treated with tamoxifen
    Pia Wegman
    Department of Clinical Medicine, School of Health and Medical Sciences, Orebro University, 701 85 Orebro, Sweden
    Int J Oncol 38:1145-51. 2011
    ..The results further strengthen a possible binding of FOXL2 to aromatase promoter I.7. Nevertheless, whether FOXL2 is a direct activator of aromatase requires further investigation...
  2. doi request reprint Genetic alterations in the K-Ras gene influence the prognosis in patients with cervical cancer treated by radiotherapy
    Pia Wegman
    Division of Clinical Medicine, School of Health and Medical Sciences, Orebro University, Orebro, Sweden
    Int J Gynecol Cancer 21:86-91. 2011
    ..The aim of this study was to investigate possible mutations in exon 1 and 2 of the K-Ras gene and to assess whether K-Ras mutation status had prognostic and predictive significance and were linked to clinicopathological parameters...
  3. doi request reprint Wwox expression may predict benefit from adjuvant tamoxifen in randomized breast cancer patients
    Anna Göthlin Eremo
    School of Health and Medical Sciences, Orebro University, SE 70182 Orebro, Sweden
    Oncol Rep 29:1467-74. 2013
    ..31, 95% CI 0.10-0.98 and HR=0.28, 95% CI 0.08-0.97, respectively). Our results indicate that patients with high expression of Wwox may gain more benefit from treatment with tamoxifen...
  4. pmc The mitochondrial transporter SLC25A43 is frequently deleted and may influence cell proliferation in HER2-positive breast tumors
    Elisabet Tina
    Clinical Research Centre, Orebro University Hospital, SE 70185, Orebro, Sweden
    BMC Cancer 12:350. 2012
    ..In HER2-positive breast cancer there are most likely unexplored proteins that act directly or indirectly downstream of well established pathways and take part in tumor development and treatment response...
  5. doi request reprint Conformational enantiomerization and estrogen receptor α binding of anti-cancer drug tamoxifen and its derivatives
    Li Gao
    Orebro Life Science Center, School of Science and Technology, Orebro University, Orebro, Sweden
    J Chem Inf Model 51:306-14. 2011
    ..For TAM and its main metabolites, the effects of the stereoselectivity of ERα are overcome by the low energy cost for helical inversion between the two torsional enantiomers, estimated to be ∼3 kcal/mol...